SCHEMBL7947208

SCHEMBL7947208

CC(C)N(N)C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NCc1ccc2ccccc2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.42
ABCC3 O15438 1/20 0.42
ABCC4 O15439 1/20 0.42
CACNA1F O60840 1/20 0.42
ABCB11 O95342 1/20 0.42
ABCB1 P08183 1/20 0.42
HTR1A P08908 1/20 0.42
DRD2 P14416 1/20 0.42
TACR2 P21452 1/20 0.42
TBXAS1 P24557 1/20 0.42
OPRM1 P35372 1/20 0.42
DRD3 P35462 1/20 0.42
AVPR1A P37288 1/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
HTR2B P41595 1/20 0.42
CACNA1D Q01668 1/20 0.42
SLC6A3 Q01959 1/20 0.42
KCNH2 Q12809 1/20 0.42
CACNA1S Q13698 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6953685 0.90 CYP3A4 (0.41) CYP3A4ABCC3ABCC4CACNA1FABCB11
SCHEMBL6952143 0.90 CYP3A4 (0.41) CYP3A4ABCC3ABCC4CACNA1FABCB11
SCHEMBL6947796 0.87 CYP3A4 (0.42) CYP3A4ABCC3ABCC4CACNA1FABCB11
SCHEMBL8861474 0.86 CYP3A4 (0.56) CYP3A4ABCC3ABCC4CACNA1FABCB11
SCHEMBL6946694 0.85 CYP3A4 (0.46) CYP3A4ABCC3ABCC4CACNA1FABCB11
SCHEMBL6947903 0.85 CYP3A4 (0.40) CYP3A4ABCC3ABCC4CACNA1FABCB11
SCHEMBL6947880 0.85 PSEN1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6953154 0.85 PSEN1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6950300 0.84 CYP3A4 (0.40) CYP3A4ABCC3ABCC4CACNA1FABCB11
SCHEMBL6947761 0.82 PSEN1 (0.46) ABCB11ABCB1OPRK1GHSRABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6258806-B1 PEPTIDES WITH CYCLIC DIAZAALKANES FOR PREVENTION OF PREMATURE METABOLISM METHOD FOR INHIBITING AN HIV PROTEASE IN A MAMMAL IN NEED OF SUCH PROTEASE INHIBITION, COMPRISING ADMINISTERING TO SAID MAMMAL AN EFFECTIVE DOSAGE NARHEX LIMITED (HK) 2001-07-10 US disclosed
US-5942504-A INHIBITORS OF RETROVIRAL PROTEASES; TREATMENT OF AIDS AND HIV NARHEX LIMITED (HK) 1999-08-24 US disclosed